selected publications
-
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma.
Cancer.
2020
Academic Article
GET IT
Times cited: 10 -
Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.
The Journal of clinical endocrinology and metabolism.
2020
Academic Article
GET IT
Times cited: 17 -
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas.
Clinical lymphoma, myeloma & leukemia.
2018
Academic Article
GET IT
Times cited: 31 -
Maintaining Bone Health During Hormonal Therapy for Prostate Cancer.
Annals of internal medicine.
2017
Comment
GET IT
Times cited: 2 -
Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy.
The oncologist.
2017
Academic Article
GET IT
Times cited: 36 -
Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.
Postgraduate medicine.
2016
Review
GET IT
Times cited: 36 -
Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score.
Journal of bone oncology.
2016
Academic Article
GET IT
Times cited: 396 - Diabetes Management in Cancer Patients. Oncology (Williston Park, N.Y.). 2016 Academic Article GET IT
-
Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia.
2016
GET IT
Times cited: 16 -
Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.
Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
2015
Academic Article
GET IT
Times cited: 16 -
Denosumab and fracture risk in women with breast cancer.
Lancet (London, England).
2015
Letter
GET IT
Times cited: 1 -
Atypical femur fractures associated with use of bisphosphonates and denosumab.
Annals of oncology : official journal of the European Society for Medical Oncology.
2015
Letter
GET IT
Times cited: 8 -
Severe Hypocalcemia Associated With Denosumab in Metastatic Castration-Resistant Prostate Cancer: Risk Factors and Precautions for Treating Physicians.
2014
GET IT
Times cited: 24 -
Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapies.
Endocrine-related cancer.
2014
Review
GET IT
Times cited: 45 -
NCCN bone health task force: key recommendations.
Journal of the National Comprehensive Cancer Network : JNCCN.
2014
Editorial Article
GET IT
Times cited: 8 -
Natural history of small radioiodine-avid bone metastases that have no structural correlate on imaging studies.
Endocrine.
2013
Academic Article
GET IT
Times cited: 19 -
NCCN Task Force Report: Bone Health In Cancer Care.
Journal of the National Comprehensive Cancer Network : JNCCN.
2013
Review
GET IT
Times cited: 159 -
Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors.
Leukemia research.
2013
Academic Article
GET IT
Times cited: 26 -
Management of metabolic effects associated with anticancer agents targeting the PI3K-Akt-mTOR pathway.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2012
Conference Paper
GET IT
Times cited: 176 -
Skeletal-related events due to bone metastases from differentiated thyroid cancer.
The Journal of clinical endocrinology and metabolism.
2012
Academic Article
GET IT
Times cited: 92 -
Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.
Oral diseases.
2012
Academic Article
GET IT
Times cited: 43 -
Serum N-telopeptide and bone-specific alkaline phosphatase levels in patients with osteonecrosis of the jaw receiving bisphosphonates for bone metastases.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
2012
Academic Article
GET IT
Times cited: 12 -
Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates.
The Journal of bone and joint surgery. American volume.
2011
Academic Article
GET IT
Times cited: 80 -
Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the bone.
Annals of the New York Academy of Sciences.
2010
Review
GET IT
Times cited: 24 -
NCCN Task Force Report: Bone Health in Cancer Care.
Journal of the National Comprehensive Cancer Network : JNCCN.
2009
Conference Paper
GET IT
Times cited: 88 -
Osteonecrosis of the jaw related to bevacizumab.
2008
GET IT
Times cited: 184 -
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
The oncologist.
2008
Academic Article
GET IT
Times cited: 114 -
Anabolic therapies for osteoporosis.
The New England journal of medicine.
2007
Letter
GET IT
Times cited: 7 -
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
Diabetes care.
2006
Letter
GET IT
Times cited: 3 -
Transient subclinical hyperparathyroidism in a patient with hashimoto's thyroiditis.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2006
Conference Paper
GET IT
Times cited: 4 -
Idiopathic renal hypercalciuria as an etiology for persistent post-operative parathyroid hormone elevation.
Surgery.
2005
Letter
GET IT
Times cited: 2 - The study on Impact 1.5 tube feedings (January-February 2005) by Farber et al . JPEN. Journal of parenteral and enteral nutrition. 2005 Letter GET IT